DB
David Bredt (Chief Scientific Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Rapport Therapeutics, Inc. (RAPP). The largest single filing was $231K of RAPP (7,704 sh × $29.95, as filed), executed Dec 15 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$807K
shares × price, as filed
Last traded
Feb 17
Filed Feb 19
Median ADV $17.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
RAPPRecent filings
RAPPSALE
Rapport Therapeutics, Inc.
View filing →
$119K8,500 sh × $14.00
Exec Jul 15 2025
Filed Jul 16 2025 · 5:30 PM ET